» Articles » PMID: 36438819

Risk Prediction Model of Polypharmacy for Community-dwelling Elderly Patients: An Assessment Tool for Early Detection

Overview
Journal Front Pharmacol
Date 2022 Nov 28
PMID 36438819
Authors
Affiliations
Soon will be listed here.
Abstract

Polypharmacy has become a major and growing public health issue, with significant implications for health outcomes and expenditure on healthcare resources. In this study, a risk prediction model of polypharmacy represented by a nomogram for community-dwelling elderly patients based on the Chinese population was constructed. A cross-sectional study was conducted in Shanghai, China. The variables data affecting polypharmacy were fetched from the information system database of health government departments in Shanghai. The Least Absolute Shrinkage Selection Operator (LASSO) regression analysis was used to select the predictor variables, and multivariate logistic regression was used to establish the prediction model. A visual tool of the nomogram was established for predicting the risk of polypharmacy in the elderly population. In addition, the receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA) were used to estimate the performance of the model. A total of 80,012 elderly patients were included in this study. Eight variables, containing age, residential area, preferred medical institutions, number of visits to tertiary hospitals, number of visits to secondary hospitals, number of visits to community health centers, number of diagnoses, and main types of disease, were included in the risk prediction model of nomogram. The area under the curve (AUC) of the nomogram was 0.782 in both sets, demonstrating that the model has a good discriminant ability. The calibration chart shows that the prediction model fits well with the validation set. DCA results displayed that the threshold probabilities of the two sets in the prediction model reached up to 90%, implying that the model had a preferable application value. This study explored the risk factors for polypharmacy among the elderly in Shanghai, China, and applied the nomogram to establish a predictive model eight variables, which provided an effective tool for early screening and timely prevention of polypharmacy. Family physicians or pharmacists could scientifically use the tool to closely observe community-dwelling elderly patients, decreasing the adverse health effects caused by medication for the elderly.

Citing Articles

Exploring medication self-management in polypharmacy: a qualitative systematic review of patients and healthcare providers perspectives.

Jin R, Liu C, Chen J, Cui M, Xu B, Yuan P Front Pharmacol. 2024; 15:1426777.

PMID: 39376612 PMC: 11456697. DOI: 10.3389/fphar.2024.1426777.

References
1.
Nicieza-Garcia M, Salgueiro-Vazquez M, Jimeno-Demuth F, Manso G . Inappropriate prescribing in polypharmacy elderly outpatients taking multiple medications. Are the STOPP criteria useful?. Int J Clin Pharmacol Ther. 2016; 54(3):172-6. DOI: 10.5414/CP202279. View

2.
Onder G, Liperoti R, Fialova D, Topinkova E, Tosato M, Danese P . Polypharmacy in nursing home in Europe: results from the SHELTER study. J Gerontol A Biol Sci Med Sci. 2012; 67(6):698-704. DOI: 10.1093/gerona/glr233. View

3.
Viktil K, Blix H, Moger T, Reikvam A . Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol. 2006; 63(2):187-95. PMC: 2000563. DOI: 10.1111/j.1365-2125.2006.02744.x. View

4.
Jorgensen T, Johansson S, Kennerfalk A, Wallander M, Svardsudd K . Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother. 2001; 35(9):1004-9. DOI: 10.1345/aph.10351. View

5.
Halli-Tierney A, Scarbrough C, Carroll D . Polypharmacy: Evaluating Risks and Deprescribing. Am Fam Physician. 2019; 100(1):32-38. View